OXIS International, Inc.

68 articles about OXIS International, Inc.

• OXIS International, Inc. Praises Biden's 'Cancer Moonshot,' Says Its Portfolio Of Targeted Immunotherapies Provides Next-Generation Cancer Treatments

  3/31/2016

• OXIS International, Inc. Continues Push For Zika Cure, Following New Confirmed Case In South Korea

  3/28/2016

• Bispecific Immunotherapy, The Basis For OXIS International, Inc.' Cancer Drug, Lauded As Promising Alternative To CAR-T Therapy

  3/22/2016

• OXIS International, Inc. Celebrates 'Clinical Trial Triumph' As Patient Passes 18 Months In Complete Cancer Remission

  2/10/2016

• OXIS International, Inc. Chairman And CEO Tells Shareholders Biotech Company Making 'Substantial Progress' With Lead Cancer Drug, Drawing Closer To NASDAQ Listing

  2/2/2016

• OXIS International, Inc. Eliminates Debt In Restructuring Deal, Will Move Forward With Phase 1/Phase 2 Clinical Trial Of Cancer Drug

  1/11/2016

• OXIS International, Inc. Announces Appointment Of Michael S. Sitrick To Business Advisory Board

  10/5/2015

• OXIS International, Inc. Announces Request For Euronext Trading Suspension

  3/31/2015

• OXIS International, Inc. Biotech Executes Option Agreement To Certain Patents/Intellectual Properties Owned By The University of Pittsburgh

  3/26/2015

• OXIS International, Inc. Biotech Issues Letter To Shareholders

  2/24/2015

• OXIS International, Inc. Announces Approval For Up-Listing To The OTCQB

  1/29/2015

• OXIS International, Inc. Announces Changes In Management Team

  11/21/2014

• OXIS International, Inc. Announces Oxis Biotech Inc., Completion Of $2.675 Million Financing, Appointment Of Chief Financial Officer And Board Member

  11/12/2014

• OXIS International, Inc. Announces Plans To Enter The Cannabis Biotech Sector, Completion Of Financing, Changes To The Board Of Directors

  8/11/2014

• OXIS International, Inc. Continues Its Global Product Rollout With the Release of Its New Prograce™ Anti-Aging Serum

  7/19/2012

• OXIS International, Inc. Joins Forces With "America's Dermatologist," Dr. Tony Nakhla and Leading PR Firm to Support Entry Into Skin Care Market With EGT(TM)

  4/24/2012

• OXIS International, Inc.l Announces Joint Venture With Global Leading Digital Marketing Firm engage:BDR to Launch New EGT(TM) Based Health and Nutrition Product Line in April

  4/17/2012

• OXIS International, Inc. Release: ERGOFLEX(TM) Joint Pain Study Published Online in Preventive Medicine

  3/28/2012

• OXIS International, Inc. Receives $1 Million Funding Commitment To Support April Launch Of Proprietary Product Line

  3/21/2012

• OXIS International, Inc. Receives GRAS Status for its Patented L-Ergothioneine Anti-Oxidant

  10/10/2011